NCT07203391 : Clinical Trial Detail - Cancer Knowledgebase (CKB)

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT07203391
Title	Tebentafusp and Roginolisib in Uveal Melanoma to Prolong T-cell Homeostasis (TRIUMPH)
Acronym	TRIUMPH
Recruitment	Recruiting
Gender	both
Phase	Phase I
Variant Requirements	No
Sponsors	St Vincent's Hospital, Sydney
Indications	uveal melanoma
Therapies	Roginolisib + Tebentafusp
Age Groups:	adult \| senior
Covered Countries	AUS

Facility	Status	City	State	Zip	Country	Details
St Vincents Hospital	RECRUITING	Sydney	New South Wales	2010	Australia	Details
Alfred Hospital	NOT_YET_RECRUITING	Melbourne	Victoria		Australia	Details

*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field

NCT07203391Clinical Trial Detail